311 related articles for article (PubMed ID: 11733630)
1. Comparison of body fluid distribution between chronic haemodialysis and peritoneal dialysis patients as assessed by biophysical and biochemical methods.
Plum J; Schoenicke G; Kleophas W; Kulas W; Steffens F; Azem A; Grabensee B
Nephrol Dial Transplant; 2001 Dec; 16(12):2378-85. PubMed ID: 11733630
[TBL] [Abstract][Full Text] [Related]
2. Fluid balance in patients with chronic renal failure assessed with N-terminal proatrial natriuretic peptide, atrial natriuretic peptide and ultrasonography.
Metry G; Hall C; Wikström B; Källskog V; Hansell P; Danielson B
Acta Physiol Scand; 2001 Feb; 171(2):117-22. PubMed ID: 11350271
[TBL] [Abstract][Full Text] [Related]
3. Assessment of dry body-weight in haemodialysis patients by the biochemical marker cGMP.
Lauster F; Gerzer R; Weil J; Fülle HJ; Schiffl H
Nephrol Dial Transplant; 1990; 5(5):356-61. PubMed ID: 2165225
[TBL] [Abstract][Full Text] [Related]
4. Changes in N-terminal pro-brain natriuretic peptide correlate with fluid volume changes assessed by bioimpedance in peritoneal dialysis patients.
Davenport A
Am J Nephrol; 2012; 36(4):371-6. PubMed ID: 23051933
[TBL] [Abstract][Full Text] [Related]
5. Atrial natriuretic peptide and cyclic guanosine-monophosphate in children and adolescents on peritoneal dialysis.
Bald M; Bonzel KE; Rascher W
Clin Nephrol; 1994 Jul; 42(1):50-3. PubMed ID: 7923967
[TBL] [Abstract][Full Text] [Related]
6. Atrial natriuretic peptide and cyclic 3'5'-guanosine monophosphate as indicators of fluid volume overload in children with chronic renal failure.
Lettgen B; Bald M; Valleé H; Bonzel KE; Rascher W
Pediatr Nephrol; 1992 Jan; 6(1):60-4. PubMed ID: 1311187
[TBL] [Abstract][Full Text] [Related]
7. The role of natriuretic peptides in volume assessment and mortality prediction in Haemodialysis patients.
Sivalingam M; Vilar E; Mathavakkannan S; Farrington K
BMC Nephrol; 2015 Dec; 16():218. PubMed ID: 26714753
[TBL] [Abstract][Full Text] [Related]
8. Plasma volume, albumin, and fluid status in peritoneal dialysis patients.
John B; Tan BK; Dainty S; Spanel P; Smith D; Davies SJ
Clin J Am Soc Nephrol; 2010 Aug; 5(8):1463-70. PubMed ID: 20538836
[TBL] [Abstract][Full Text] [Related]
9. Relationship of demographic, dietary, and clinical factors to the hydration status of patients on peritoneal dialysis.
Asghar RB; Green S; Engel B; Davies SJ
Perit Dial Int; 2004; 24(3):231-9. PubMed ID: 15185771
[TBL] [Abstract][Full Text] [Related]
10. [Measurement of water content and distribution using whole-body multifrequency impedance in a healthy population in diseases of the kidney].
Kotyk P; Lopot F; Bláha J; Sulková S
Cas Lek Cesk; 1995 Nov; 134(22):723-6. PubMed ID: 8599810
[TBL] [Abstract][Full Text] [Related]
11. Intraindividual comparison of ANP, cGMP and plasma catecholamines between HD and CAPD.
Plum J; Ziyaie M; Kemmer FW; Passlick-Deetjen J; Grabensee B
Adv Perit Dial; 1990; 6():211-9. PubMed ID: 1982811
[TBL] [Abstract][Full Text] [Related]
12. Clinical significance of natriuretic peptides and cyclic GMP in hemodialysis patients with coronary artery disease.
Osajima A; Okazaki M; Kato H; Anai H; Tsuda Y; Segawa K; Tanaka H; Tamura M; Takasugi M; Nakashima Y
Am J Nephrol; 2001; 21(2):112-9. PubMed ID: 11359018
[TBL] [Abstract][Full Text] [Related]
13. Impact of profile haemodialysis on intra-/extracellular fluid shifts and the release of vasoactive hormones in elderly patients on regular dialysis treatment.
Ebel H; Laage C; Keuchel M; Dittmar A; Saure B; Ehlenz K; Lange H
Nephron; 1997; 75(3):264-71. PubMed ID: 9069446
[TBL] [Abstract][Full Text] [Related]
14. Impact of Diabetes on Extracellular Volume Status in Patients Initiating Peritoneal Dialysis.
Udo A; Goodlad C; Davenport A
Am J Nephrol; 2017; 46(1):18-25. PubMed ID: 28564640
[TBL] [Abstract][Full Text] [Related]
15. Plasma cGMP level as a marker of the hydration state in renal replacement therapy.
Lauster F; Heim JM; Drummer C; Fülle HJ; Gerzer R; Schiffl H
Kidney Int Suppl; 1993 Jun; 41():S57-9. PubMed ID: 8391608
[TBL] [Abstract][Full Text] [Related]
16. Comparative effects of haemodialysis and haemofiltration on plasma atrial natriuretic peptide.
Raine AE; Bock A; Muller FB; Erne P; Bolli P; Brunner F; Buhler FR
Nephrol Dial Transplant; 1989; 4(3):222-7. PubMed ID: 2524680
[TBL] [Abstract][Full Text] [Related]
17. Plasma brain natriuretic peptide concentration on assessment of hydration status in hemodialysis patient.
Lee SW; Song JH; Kim GA; Lim HJ; Kim MJ
Am J Kidney Dis; 2003 Jun; 41(6):1257-66. PubMed ID: 12776279
[TBL] [Abstract][Full Text] [Related]
18. Is there a role for N-terminal probrain-type natriuretic peptide in determining volume status in haemodialysis patients?
Kumar S; Khosravi M; Massart A; Davenport A
Nephron Clin Pract; 2012; 122(1-2):33-7. PubMed ID: 23548328
[TBL] [Abstract][Full Text] [Related]
19. Atrial natriuretic peptide (ANP) in patients with chronic renal failure on maintenance haemodialysis.
de Châtel R; Makó J; Tóth M; Barna I; Lang RE
Int Urol Nephrol; 1991; 23(2):177-83. PubMed ID: 1830872
[TBL] [Abstract][Full Text] [Related]
20. Differences in prescribed Kt/V and delivered haemodialysis dose--why obesity makes a difference to survival for haemodialysis patients when using a 'one size fits all' Kt/V target.
Davenport A
Nephrol Dial Transplant; 2013 Nov; 28 Suppl 4():iv219-23. PubMed ID: 23787543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
